Neuberg Diagnostics raises Rs.940 crore from Kotak Alt
In one of the largest fundraising in the Indian diagnostics sector, Chennai-based Neuberg Diagnostics has said it has raised Rs.940 crore from Kotak Alt.
“We are thrilled to announce that Neuberg Diagnostics has secured an investment from Kotak Alt marking a significant milestone in our journey toward becoming one of the largest diagnostics chains of Indian origin. This funding will enable us to enhance our capabilities in the areas of personalized medicine, and integrated diagnostics and inorganically expand our footprint across the country,” Dr GSK Velu, Founder and Managing Director, Neuberg Diagnostics said.
According to Rahul Shah, Partner at Kotak Alt, the investment reflects the company’s confidence in Neuberg’s vision and potential.
“We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and help the Company get ready for its upcoming IPO (Initial Public Offering). This investment solidifies our commitment to supporting quality healthcare solutions that improve patient outcomes and accessibility,” Shah added.
Neuberg Diagnostics is one of the top four largest diagnostics providers in India with a network spanning 10,000 touchpoints and over 250 laboratories across 250 cities.
Additionally, Neuberg Diagnostics ranks as one of the top two genomics players in India and holds a leadership position in newborn screening and reproductive genomics testing.
(Venkatachari Jagannathan can be reached at venkatacharijagannathan@gmail.com)
